Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Kennedy To Industry: User Fees Still In Play If Third Party Sits This One Out

This article was originally published in The Gray Sheet

Executive Summary

Industry supporters of medical device user fees are assuming a formidable challenge by linking the legislative proposal with the "Medical Device Amendments of 2001" (HR 3580), introduced by Reps. Jim Greenwood (R-Penn.) and Anna Eshoo (D-Calif.)

You may also be interested in...



IVD National Fee Schedule, MDUFMA Oversight Among AdvaMed 2003 Goals

Securing adequate Medicare payment for in vitro diagnostics is one of several legislative priorities for AdvaMed in 2003

IVD National Fee Schedule, MDUFMA Oversight Among AdvaMed 2003 Goals

Securing adequate Medicare payment for in vitro diagnostics is one of several legislative priorities for AdvaMed in 2003

Device User Fee Program Faces Initial Implementation, Funding Challenges

HHS' FY 2004 budget request will likely seek to rectify a potential shortfall in funds needed to sustain FDA's device user fee program through FY 2007

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT016622

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel